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Research approaches to bioﬁlm are stratiﬁed by a series of analyses: (1) microbial number and species;
(2) microbial proteins, such as enzymes; and (3) microbial activity, such as metabolic activity. On the
other hand, the hierarchical structure of biology includes the genome, proteome, and metabolome, in
which the metabolome is the ﬁnal output of biological function. Metabolome analysis is the
comprehensive analysis of the metabolome, a new strategy for biological research in the 21st century.
The stratiﬁed structure of bioﬁlm research corresponds to the biological hierarchy, and the analysis of
microbial activity, especially metabolic activity, is comparable to metabolome analysis; however, oral
bioﬁlm samples are too small to analyze the metabolome by conventional methods. Recently, a new
device involving capillary electrophoresis (CE) and time-of-ﬂight mass spectrometry (MS) has been
developed, facilitating metabolomic investigation of the central carbon metabolic pathways (i.e., the
EMP pathway, pentose phosphate pathway, and TCA cycle) in oral bioﬁlm. Using CE–MS, we analyzed
metabolome proﬁles of oral bioﬁlm after oral rinsing with glucose in vivo and evaluated the effects of
oral rinsing with ﬂuoride and xylitol on the metabolome proﬁles of oral bioﬁlm. The results were
somewhat consistent with previous in vitro data obtained from single bacterial strains, namely,
Streptococcus and Actinomyces; however, new information describing the metabolic properties of oral
bioﬁlm was also obtained. This metabolomic approach will reveal the functional characteristics of oral
bioﬁlm in vivo, potentially providing new insights into the nature of oral bioﬁlm in health and disease.
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The term ‘‘oral bioﬁlm,’’ also often referred to as dental plaque
or the oral microbial community, refers to the complex of
microorganisms in the oral environment and their nonmicrobialciation for Oral Biology. Published
: þ81 22 717 8297.
ahashi).surroundings. Research approaches to oral bioﬁlm are stratiﬁed as
analyses of (1) microbial composition (recently termed the
‘‘microbiome’’), (2) microenvironments, and (3) functions of the
microbial community. Among them, the functions of the micro-
bial community, such as metabolic activity, are crucial ﬁnal
outputs, because they directly relate to the pathogenicity of oral
diseases (e.g., organic acids to dental caries, short fatty acids and
sulﬁdes to periodontal diseases, and sulﬁdes and ammonia to
halitosis) [1].by Elsevier B.V. All rights reserved.
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Fig. 1. Biological hierarchy from genome to transcriptome/proteome and meta-
bolome, relevant to research strategies in cariogenic oral bioﬁlm.
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beginning with the genome and culminating in the metabolome,
has been proposed (Fig. 1). The genome is a set of genes that
represents a series of information describing gene function. This
set of genes can be transcribed into a set of messenger RNAs;
these make up the transcriptome. The transcriptome is then
translated into a set of proteins, or the proteome. The transcrip-
tome and proteome represent the potential to function, that is,
metabolic reactions catalyzed by enzyme activities. Then, a set of
metabolites that make up the so-called metabolome is produced.
The metabolome is the predominant ﬁnal output of the biological
hierarchy, and metabolome analysis or metabolomics is a new
strategy for biological research in the 21st century.
The biological hierarchy seems to correspond to the stages of
research into oral bioﬁlm (Fig. 1). The genome is equivalent to the
microbial composition (microbiome), and the transcriptome or
proteome is like a list of microbial enzymes. The metabolome is
the primary ﬁnal output of the metabolism of oral bioﬁlm and is
also a crucial ﬁnal output of oral bioﬁlm, which directly relates to
pathogenicity.2. Metabolic activity: the ﬁnal output of the biological
hierarchy, which inﬂuences upper layers of the hierarchy
Furthermore, microbial metabolites or the metabolome can
inﬂuence the upper layers of the biological hierarchy [1–3]. For
example, in supragingival plaque bioﬁlm, the ﬁnal output is acid
production, and this is directly associated with dental caries
formation (Fig. 1).
The acids produced by supragingival plaque cause environ-
mental acidiﬁcation and subsequently inﬂuence microbial
enzyme activities (acid-induced modiﬁcations of enzymatic activ-
ity) [4,5]. Transcription and translation are also regulated by
environmental acidiﬁcation (acid-induced adaptation through
the induction of proteins/enzymes) [6–8]. In addition, the acid-
iﬁed environment causes a shift in microbial composition through
microbial selection over acid stress (acid-induced selection of
microorganisms). This cycle will continue as long as environ-
mental acidiﬁcation persists as a driving force.
Acid produced through microbial metabolism is a direct factor
contributing to the development of dental caries. Furthermore,
the acidic environment established by microbial metabolism is
also an indirect factor contributing to dental caries, since caries
activity can be enhanced through the acid-induced modiﬁcation
of enzymatic activity, adaptation of enzymes, and selection of
microbial composition. Therefore, in order to elucidate the
cariogenicity of supragingival plaque bioﬁlm, it is not enough to
analyze microbial composition (microbiome) (i.e., answer thequestion, ‘‘Who are they?’’). Instead, elucidation of the metabo-
lism of supragingival plaque bioﬁlm in vivo (i.e., answer the
question, ‘‘What are they doing there?’’) will be more crucial [9].3. The central carbon metabolism in oral bioﬁlm, derived
from previous studies using a single bacterial species in vitro
The central carbon metabolism starts with classic glycolysis, the
Embden–Meyerhof–Parnas (EMP) pathway, in which 1 molecule of
glucose is degraded into 2 molecules of pyruvate, and under
anaerobic conditions, pyruvate can further be degraded into lactate
by the catalysis of lactate dehydrogenase and formate and acetate
by pyruvate formate-lyase catalysis (A in Fig. 2). These pathways
are shared by oral species of Streptococcus, Actinomyces, and
Lactobacillus. In the presence of oxygen, pyruvate can be converted
to acetate by the catalysis of pyruvate dehydrogenase or pyruvate
oxidase in Streptococcus and Lactobacillus (B in Fig. 2), while lactate
can be converted to acetate by the combination of lactate dehy-
drogenase and pyruvate oxidase in Actinomyces (C in Fig. 2). In the
presence of bicarbonate, which is one of the salivary components,
phosphoenolpyruvate can be converted to succinate with bicarbo-
nate assimilation by phosphoenolpyruvate carboxylase and/or
phosphoenolpyruvate carboxykinase, using part of the tricar-
boxylic acid (TCA) cycle (D in Fig. 2). This pathway is shared by
Actinomyces [10–12].
These metabolic pathways have been elucidated using a single
bacterial strain; however, although supragingival plaque bioﬁlm
consists mainly of oral species of Streptococcus, Actinomyces, and
Lactobacillus [13,14], it is not clear whether these pathways
function in supragingival plaque in vivo. In addition, there is no
information on the metabolic function of the pentose-phosphate
pathway and the rest of the TCA cycle in oral bioﬁlm. However,
the amount of supragingival plaque sampled from the oral cavity
is too small to perform a metabolism study using conventional
biochemical methods. In order to overcome this difﬁculty, meta-
bolome analysis is an excellent candidate approach.4. Metabolome analysis of oral bioﬁlm using a combination of
capillary electrophoresis and time-of-ﬂight mass spectrometry
(CE–MS)
Metabolome analysis is the comprehensive identiﬁcation and
quantiﬁcation of metabolites in biological systems and is one of
the most powerful approaches for metabolism research. Capillary
electrophoresis (CE) combined with time-of-ﬂight mass spectro-
metry (MS), or CE–MS, has been proven suitable to separate and
quantify metabolites involved in the central carbon metabolism,
including the EMP pathway, pentose-phosphate pathway, and
TCA cycle [9,12,15,16]. CE is an excellent separator of ionized
small molecules, such as metabolic intermediates, most of which
are polar and ionic small molecules, while MS is an excellent
technique for analysis of molecular mass. Using this system, it
was possible to analyze as little as 10 mg of supragingival plaque
and to identify and quantify most metabolic intermediates of the
central carbon metabolism, as well as xylitol 5-phosphate formed
by bacterial phosphorylation of xylitol (E in Fig. 2).
Table 1 shows the ﬁrst metabolomic analysis of human
supragingival plaque before and after a glucose rinse in vivo
[12]. Five volunteers (periodontally healthy, with 0.4070.45
decayed teeth, not taking any antibiotics) were recruited to
accumulate plaque by refraining from tooth brushing overnight.
After conﬁrming that the volunteers had not consumed any
food for at least 2 h, supragingival plaque covering half the
dentition of each volunteer was collected using sterilized
G6P 
F6P 
F1,6BP 
DHAP
PEP  
Pyruvate
6PG
Ribose 5P
S7P G3P
2PG
Citrate
Cis-aconitate
2-Oxoglutarate
Succinyl CoA
SUCCINATE
Fumarate
Malate
Oxaloacetate
Isocitrate
Xylulose 5P
Erythrose 4P
Ribulose 5P
3PG 
Acetyl CoA
LACTATE
GLUCOSE 
ACETATE
FORMATE
Pentose-phosphate
pathway
EMP pathway
TCA cycle
ACETATE
CO2
O2
O2
A
B
C
D
Xylitol 5-phosphate 
XYLITOL 
E
Fig. 2. The central carbon metabolism pathways, including the EMP pathway, pentose-phosphate pathway, and TCA cycle. A, metabolic pathways shared by oral
Streptococcus, Actinomyces, and Lactobacillus (Glucose- Lactate, Acetate and Formate); B, metabolic pathway shared by oral Streptococcus, Actinomyces, and Lactobacillus
under aerobic conditions (Pyruvate- Acetate); C, metabolic pathway shared by oral Actinomyces (Lactate- Acetate); D, metabolic pathways shared by oral Actinomyces
in the presence of bicarbonate (PEP - Succinate); E, xylitol phosphorylation by S. mutans. G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; F1,6BP, fructose 1,6-
bisphosphate; DHAP, dihydroxyacetone phosphate; G3P, glyceraldehyde 3-phosphate; 2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; PEP, phosphoenolpyruvate;
6PG, 6-phosphogluconate; Ribulose 5P, ribulose 5-phosphate; Ribose 5P, ribose 5-phosphate; S7P, sedoheptulose 7-phosphate; E4P, erythrose 4-phosphate. Metabolites in
italics were not detectable by the CE–MS system.
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10 mL of 10% glucose for 60 s, and 10 min after rinsing, supra-
gingival plaque was collected from the rest of the dentition of
each volunteer. Plaque samples were immediately immersed in
ice-cold methanol after collection, and metabolites extracted
from samples were analyzed by CE–MS. Analytical conditions
for CE–MS are described in detail in the previous report [12].
This analysis demonstrated that the CE–MS method was
capable of the comprehensive identiﬁcation and quantiﬁcation
of metabolites in the central carbon metabolism, contained in a
small amount of supragingival plaque. The results showed that
supragingival plaque contained all the targeted metabolites in the
central carbon metabolism, with no detection of erythrose
4-phosphate in the pentose-phosphate pathway and low detec-
tion of cis-aconitate and isocitrate in the TCA cycle (Table 1). After
the glucose rinse, glucose 6-phosphate, fructose 6-phosphate,
dihydroxyacetone phosphate, and pyruvate in the EMP pathway,
as well as ribulose 5-phosphate and sedoheptulose 7-phosphate
in the pentose-phosphate pathway increased signiﬁcantly. There
were also many variations in the levels of metabolic intermedi-
ates after the glucose rinse, although these were not statistically
signiﬁcant. Lactate also increased after the glucose rinse (Table 1).
In addition, metabolome proﬁles found in supragingival plaque
in vivo were basically similar to those obtained from in vitro
metabolic experiments of representative oral bacteria, Streptococ-
cus mutans, Streptococcus sanguinis, Actinomyces naeslundii, and
Actinomcyes oris [12].These results revealed that the EMP pathway, pentose-phos-
phate pathway, and TCA cycle function in supragingival plaque
microbiota in vivo. Upon glycolytic activation, metabolites in the
pentose-phosphate pathway also increased, indicating an asso-
ciated regulation between the EMP and pentose-phosphate path-
ways. Furthermore, these metabolic pathways seemed to be the
integration of metabolic pathways of representative plaque
bacteria, namely, Streptococcus and Actinomyces [12], reﬂecting
cohabitation of these bacteria in the supragingival plaque bioﬁlm
[13,14]. These results suggest that bacterial metabolic studies
in vitro could be valid for the assessment of in vivo bacterial
metabolic phenomena if the experimental conditions were well
designed and that metabolomics approaches to microbiota, such
as dental plaque, may give insight into the entire metabolic
system and its mutual regulation within the microbiota.5. Effects of xylitol and ﬂuoride on the metabolome proﬁle of
oral bioﬁlm in vivo
Fluoride and xylitol have been used worldwide as representa-
tive caries preventive reagents. Fluoride inhibits demineralization
and promotes remineralization of the tooth surface [17,18] and is
also known to inhibit bacterial acid production in vitro [19–21]
and plaque acid production in vivo [22,23]. Previous in vitro
studies, using oral streptococci, revealed that ﬂuoride inhibits
enolase, an enzyme in the EMP pathway [24–27]; however, the
Table 1
Metabolome proﬁles before and after rinsing with 10 mL of 10% glucose for 60 s in
supragingival plaque in vivo (nmol/mg of wet weight of plaque) (modiﬁed from ).
Takahashi et al., 2010 [12]
Metabolite Before glucose rinse After glucose rinse
EMP pathway
Glucose 6-phosphate 0.13370.002 0.44270.087*
Fructose 6-phosphate 0.03370.006 0.10870.025*
Fructose 1,6-bisphosphate 0.02470.010 0.09970.083
Dihydroxyacetone phosphate 0.03770.004 0.07470.011*
3-Phsophoglycerate 0.24570.165 0.21870.159
Phosphoenolpyruvate 0.09470.035 0.06270.037
Pyruvate 0.58870.461 4.23672.731**
Pentose phosphate pathway
6-Phosphogluconate 0.00870.003 0.03370.017
Ribulose 5-phosphate 0.02970.014 0.05470.021*
Ribose 5-phosphate 0.01170.007 0.03670.028
Sedoheptulose 7-phosphate 0.05870.019 0.14370.041*
Erythrose 4-phosphate nd nd
TCA cycle
Acetyl-CoA 0.02070.006 0.04570.019
Citrate 0.03870.031 0.01770.006
cis-Aconitate 0.00270.003 0.00070.009
Isocitrate 0.00170.002 nd
2-Oxoglutarate 0.01370.013 0.02370.012
Succinyl CoA 0.01170.018 0.01970.022
Succinate 1.83471.320 1.65071.001
Fumarate 0.03470.039 0.01970.019
Malate 0.10570.059 0.07470.044
Lactate 1.73770.823 13.124712.712*
EMP pathway, Embden–Meyerhof–Parnas pathway; TCA cycle, tricarboxylic acid
cycle; nd, not detected; Succinyl CoA, succinyl coenzyme A.
n Signiﬁcantly different from the amount of metabolites before glucose rinse
(po0.002 by t test with Bonferroni correction).
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Fig. 3. Changes in metabolome proﬁles in the EMP pathway and lactate after
rinsing with a glucose–xylitol mixture or sodium ﬂuoride plus glucose (modiﬁed
from Takahashi and Washio, 2011 [34]). Changes are expressed as the ratio of the
amount (nmol/mg wet weight of plaque) of metabolites and lactate after rinsing
with a glucose–xylitol mixture or ﬂuoride (225 or 900 ppm F) plus glucose to
that of metabolites after rinsing with glucose. *, Signiﬁcantly different from the
amount of metabolites present after rinsing with glucose (po0.017 by t-test with
Bonferroni correction).
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has not been conﬁrmed in oral bioﬁlm, which consists of multiple
species of bacteria in vivo.
On the other hand, xylitol, a nonfermentative sugar alcohol,
does not cause dental caries, similarly to other sugar alcohols.
Xylitol is known to repress the production of acid from glucose by
S. mutans through the inhibition of glycolytic enzymes by xylitol
5-phosphate, an enzyme produced from xylitol through a con-
stitutive phosphoenolpyruvate–fructose phosphotransferase
system (E in Fig. 2) [28–31]. Furthermore, xylitol 5-phosphate is
dephosphorylated and returned to xylitol, resulting in the forma-
tion of a ‘‘futile cycle,’’ an energy-wasting cycle, and subsequent
repression of S. mutans growth [32,33]. Although it is true that
xylitol does not cause dental caries, the mechanism through
which xylitol exerts its inhibitory has not been conﬁrmed in oral
bioﬁlm in vivo.
Seven volunteers (periodontally healthy, with 0.1470.38
decayed teeth, not taking any antibiotics) were recruited to
accumulate plaque, and supragingival plaque covering half the
dentition of each volunteer was collected as described in Section 4.
Subsequently, the volunteers were asked to rinse with 10 mL of
10% glucose, a 10% glucose-10% xylitol mixture, or sodium
ﬂuoride (225 or 900 ppm F) for 60 s. After 10 min, volunteers
who had rinsed with glucose or the glucose–xylitol mixture were
subjected to supragingival plaque sampling from the rest of the
dentition. The volunteers who had rinsed with sodium ﬂuoride
were asked to rinse with 10 mL of 10% glucose for 60 s, and after
10 min, supragingival plaque was collected from the rest of the
dentition of each of these volunteers as well. Plaque samples were
treated and analyzed as described in Section 4, except for xylitol
5-phosphate [34].
Fig. 3 shows the effects of xylitol and ﬂuoride on glucose
metabolism in supragingival plaque in vivo. The effects of thesedental washes were evaluated by determining changes in the
amounts of metabolites and lactate in supragingival plaque.
Changes were expressed as the ratio of the amount of metabolites
after rinsing with the glucose–xylitol mixture or ﬂuoride plus
glucose to the amount of metabolites after rinsing with glucose.
When xylitol was added to glucose, there was no signiﬁcant
change in the metabolite proﬁle or lactate production in supra-
gingival plaque in vivo (Fig. 3). Xylitol 5-phosphate was detected
at a signiﬁcant level only after rinsing with the glucose–xylitol
mixture [34], as previously reported [28], supporting that xylitol
5-phosphate is produced via a bacterial phosphoenolpyruvate-
dependent phosphotransferase system [28,30,31]. However, the
presence of xylitol 5-phosphate does not seem to inﬂuence
glucose fermentation by supragingival plaque in vivo, although
it is unknown whether such xylitol 5-phosphate formation may
be involved in the ‘‘futile cycle.’’ This may be because dental
plaque covering the clinically healthy tooth surface contains only
a small number of mutans streptococci [35,36] or because xylitol
5-phosphate is not as effective in vivo as in vitro. It seems that the
role of xylitol in caries prevention is as a nonfermentative sugar
substitute, since no lactate production from xylitol and no effect
of xylitol on the metabolome proﬁle were observed.
On the other hand, when ﬂuoride was added to the oral cavity
before glucose rinsing, 3-phosphoglycerate accumulated, suggest-
ing that ﬂuoride inhibited this metabolic step, catalyzed by the
glycolytic enzyme enolase, which catalyzes the production of
phosphoenolpyruvate (arrow in Fig. 3) [34]. Lactate production
was also decreased signiﬁcantly. This phenomenon is similar to
the well-known ﬂuoride-based inhibition of enolase, which has
been demonstrated through in vitro experiments in S. mutans and
S. sanguinis [25,27].
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fructose 6-phosphate, and fructose 1,6-bisphosphate and a
decrease in dihydroxyacetone phosphate were also observed
(Fig. 3), indicating the inhibition of aldolase, glyceraldehyde
3-phosphate dehydrogenase, and/or phosphoglycerate kinase in
the EMP pathway, although there are no reports demonstrating
this type of inhibition in either S. mutans or S. sanguinis [25,27].
Further studies are needed to clarify this phenomenon by inves-
tigating other plaque bacteria.
These series of results suggest the favorable potential of
metabolome analysis in the investigation of the mechanisms
through which medicinal agents (such as ﬂuoride) and dietary
ingredients (such as xylitol) inﬂuence the metabolic aspects of
oral bioﬁlm.6. Conclusions: metabolomic approaches may answer the
questions, ‘‘What are they doing?’’, ‘‘How are they
controlled?’’, and more
In oral bioﬁlm research, the analysis of microbial composition
(the microbiome) is still the main paradigm, and, along with the
progress of metagenomic technology, microbial analysis will
eventually provide a comprehensive answer to the question,
‘‘Who are they?’’ However, most oral microorganism-mediated
diseases, such as dental caries, periodontal disease, and oral
malodor, are initiated and promoted by microbial metabolic
activity, not only by the presence of speciﬁc microorganisms;
for example, dental caries occurs under acidic conditions estab-
lished by bacterial acid production, irrespective of the bacterial
species. Thus, strategies to prevent these diseases do not neces-
sarily need to involve killing or eliminating these microorganisms,
but rather controlling their metabolic activity and consequently
their growth and pathogenicity. Metabolome analysis, capable of
analyzing the metabolic characteristics of oral bioﬁlm, such as
metabolic pathways and metabolic regulatory mechanisms
in vivo, may answer the questions, ‘‘What are they (the micro-
biota) doing?’’ and ‘‘How are they controlled?’’ As described in
this review, metabolic approaches to dental caries have been
developed; however, those for periodontitis and oral malodor
have not yet been established, probably due to difﬁculties in the
identiﬁcation of metabolites relevant to metabolic pathways, such
as amino acids and amino sugars. Further development of
analytical techniques and metabolite databases, as well as basic
research for microbial metabolic pathway, is needed.
It has also become more important to understand the whole
physiological function of oral bioﬁlm, e.g., how the balance of oral
bioﬁlm is maintained (symbiosis) and how the balance shifts
toward the pathogenic condition (dysbiosis) [1–3,37]. Metabo-
lome analysis is a powerful tool to probe the metabolic char-
acteristics of the entire oral bioﬁlm, and this may provide new
insights into the nature of oral bioﬁlm in health and disease.
Furthermore, metabolome analysis may enable us not only to
characterize the metabolic properties of oral bioﬁlm in vivo, but
also to elucidate drug efﬁcacy in vivo, from classical cariostatic
ﬂuoride to new-generation oral disease-preventive agents, and to
identify new biomarkers relevant to oral diseases.
These considerations may lead us to the hypothesis that oral
bioﬁlm consists of a tremendous number of microorganisms, but
functions as one organism or a as multicellular system. This is a
realistic, reasonable hypothesis because it is known that micro-
organisms present in oral bioﬁlm live together through inter-
microorganism communication, including co-adhesion/aggrega-
tion, metabolic interactions, bacteriocin release, quorum sensing,
gene exchange, etc. [38–41], and cooperate and compete through
adaptation to and selection by environmental alteration, such asnutrition, pH, and reduction–oxidation potential, and even
through modiﬁcation of the environment [1–3,10,37,42–44].
Recently, it has been suggested that humans are a human-
microbiota hybrid, where host tissue and symbiotic microorgan-
isms function together and inﬂuence each other, a so-called
‘‘superorganism’’ [45]. With this concept, the metabolomic
approach may open a new era in the research of symbiotic
microbiota, including oral bioﬁlm, and metabolome analysis is
just the beginning.Conﬂict of interest
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